Open Demat Account
Become a
New
Partner
Products &
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
TraderX
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Formulations
Share
Kilitch Drugs (India) Ltd Share Price
Pharmaceuticals - Indian - Formulations
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
345.35
341.20
Date :
Apr 25,2025 EOD
-9.35
(-2.64)
-2.81
(-9.85)
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
359.95
Buy (size)
0.00(x0)
Sell (size)
345.35(×1)
Buy Qty
0
Sell Qty
1
Today's High
(₹)
369.95
Today's Low
(₹)
340.00
52 Week High
(₹)
404.95
52 Week Low
(₹)
299.95
Market Statistics
Div Yield (%)
0
EPS
14.57
Book Value
117.72
Market Cap
548.73
Face Value
10
Market Lot
1
AGM Date
Sep
Closure Date
Sep
ISIN No
INE729D01010
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
11134173
Total of Promoter
11134173
Non Promoter (Institution)
100
Non Promoter (Non-Institution)
4948046
Total Non Promoter
4948146
Total Promoter & Non Promoter
16082319
Custodians(Against Depository Receipts)
0
Grand Total
16082319
News
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Announcement unde..
07-Apr-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Announcement under Regulation 30 (LODR)-Retirement
We hereby inform you that Mr. Hemang Jagadish Engineer has completed his secon term as Independent Director of the Company on 31st March 2025
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Closure of Tradin..
26-Mar-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Closure of Trading Window
Trading Window for dealing in securities of the Company will remain closed for all the Designated Persons of the Company with effect from Tuesday 1st April 2025 till expiry of 48 hours after declaration of Financial Results of the Company
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (In..
26-Mar-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (India) Limited - Trading Window
Kilitch Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Announcement unde..
14-Feb-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby inform the exchange regarding newspaper publication of the extract of the financial result for the quarter ending 31st December 2024
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (In..
14-Feb-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (India) Limited - Copy of Newspaper Publication
Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (In..
14-Feb-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (India) Limited - Copy of Newspaper Publication
Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) consolidated net profit..
12-Feb-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) consolidated net profit rises 104.81% in the December 2024 quarter
Net profit of Kilitch Drugs (India) rose 104.81% to Rs 5.96 crore in the quarter ended December 2024 as against Rs 2.91 crore during the previous quarter ended December 2023. Sales rose 76.69% to Rs 56.17 crore in the quarter ended December 2024 as against Rs 31.79 crore during the previous quarter ended December 2023.
Particulars
Quarter Ended
Dec. 2024
Dec. 2023
% Var.
Sales
56.17
31.79
77
OPM %
15.54
7.17
-
PBDT
9.06
3.64
149
PBT
8.25
2.82
193
NP
5.96
2.91
105
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (In..
12-Feb-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (India) Limited - Press Release
Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated February 12, 2025, titled 'Financial Results Q3FY25'.
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) to convene board meetin..
04-Feb-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) to convene board meeting
Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 February 2025.
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (In..
04-Feb-2025
Read More
Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd - Kilitch Drugs (India) Limited - Board Meeting
Kilitch Drugs (India) Limited has informed the Exchange about Board Meeting to be held on 11-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
Corporate Details
Board of Directors
Incorporation Year
1992
Chairman
Mukund P Mehta
Auditor
Suryaprakash Maurya & Co
Face Value
10
Market Lot
1
Listing
BSE,MSEI,NSE,
Registered Office
37 Ujagar Industrial Estate W T Patil Marg Deonar MR Maharashtra Mumbai400088
Contact
Telephone: 91-022-27670322/27680913/65144185
Fax: 91-022-27680912
Chairman & Managing Director
Mukund P Mehta
Whole-time Director
Bhavin M Mehta
Independent Director
Hemang Engineer
Managing Director
Mira Bhavin Mehta
Independent Director
Murti Vasudev Krishna
Venkita Subramanian Rajan
Company Sec. & Compli. Officer
Pushpa Nyoupane
Independent Director
Dipen Jayantilal Jain
Mutual Fund Holdings
1-0
of 0
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
FAQ
What is the share price of Kilitch Drugs (India) Ltd today on NSE and BSE?
The Kilitch Drugs (India) Ltd Share price on NSE is Rs.345.35 and BSE Rs.341.20 as on today
How to buy Kilitch Drugs (India) Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Kilitch Drugs (India) Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Kilitch Drugs (India) Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Kilitch Drugs (India) Ltd is 548.73
What are the key financial ratios to analyse Kilitch Drugs (India) Ltd Share Price?
Kilitch Drugs (India) Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 23.42
ROE ratio: 8.39
Debt to Equity ratio: 0.13
EPS: 14.57
When did Kilitch Drugs (India) Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Kilitch Drugs (India) Ltd issued bonus shares last in NA
What is the 52 week highest and lowest share price value of Kilitch Drugs (India) Ltd?
The highest share price value is Rs. 404.95 and Lowest share price value is Rs. 299.95 for 52 week period for Kilitch Drugs (India) Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Kilitch Drugs (India) Ltd?
NA has the highest amount invested with Kilitch Drugs (India) Ltd.
Which year Kilitch Drugs (India) Ltd was incorporated?
Kilitch Drugs (India) Ltd was incorporated in 1992
What is the stock symbol of Kilitch Drugs (India) Ltd?
The stock symbol for Kilitch Drugs (India) Ltd shares is KILITCHDRUGS(INDIA)LTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
ABL Bio-Technologies Ltd
526955
Not Listed
ACE Laboratories Ltd
526077
ACELAB
Adline Chem Lab Ltd
524604
Not Listed
Aesculapius Remedies Ltd (Wound-up)
531786
Not Listed
Ahlcon Parenterals (India) Ltd
524448
Not Listed
Ajanta Pharma Ltd
532331
AJANTPHARM
Alpa Laboratories Ltd
532878
ALPA
Alps Laboratories Ltd
526003
Not Listed
American Remedies Ltd (Merged)
531534
Not Listed
Amrutanjan Health Care Ltd
590006
AMRUTANJAN
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
25 Apr 2025
7,232.00
4,012.00
55.48
24 Apr 2025
18,538.00
4,790.00
25.84
23 Apr 2025
8,055.00
3,354.00
41.64
22 Apr 2025
2,498.00
1,704.00
68.21
21 Apr 2025
5,637.00
2,811.00
49.87
17 Apr 2025
12,515.00
6,949.00
55.53
16 Apr 2025
3,744.00
2,241.00
59.86
15 Apr 2025
13,462.00
6,738.00
50.05
11 Apr 2025
4,239.00
2,363.00
55.74
09 Apr 2025
9,596.00
6,959.00
72.52
08 Apr 2025
3,604.00
1,710.00
47.45
07 Apr 2025
10,685.00
5,003.00
46.82
04 Apr 2025
31,234.00
18,716.00
59.92
03 Apr 2025
23,914.00
11,231.00
46.96
02 Apr 2025
11,535.00
7,486.00
64.90
01 Apr 2025
29,546.00
19,477.00
65.92
28 Mar 2025
19,375.00
13,850.00
71.48
27 Mar 2025
11,757.00
7,855.00
66.81
26 Mar 2025
4,584.00
2,650.00
57.81
Please wait ...